0001348362-24-000005.txt : 20241016 0001348362-24-000005.hdr.sgml : 20241016 20241016153014 ACCESSION NUMBER: 0001348362-24-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241016 DATE AS OF CHANGE: 20241016 EFFECTIVENESS DATE: 20241016 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lexaria Bioscience Corp. CENTRAL INDEX KEY: 0001348362 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 202000871 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-526964 FILM NUMBER: 241374424 BUSINESS ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 BUSINESS PHONE: 250-765-6424 MAIL ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 FORMER COMPANY: FORMER CONFORMED NAME: LEXARIA CORP. DATE OF NAME CHANGE: 20080229 FORMER COMPANY: FORMER CONFORMED NAME: Lexaria Corp. DATE OF NAME CHANGE: 20051229 D 1 primary_doc.xml X0708 D LIVE 0001348362 Lexaria Bioscience Corp. 100 - 740 MCCURDY ROAD KELOWNA A1 BRITISH COLUMBIA, CANADA V1X 2P7 250-765-6424 NEVADA LEXARIA CORP. Lexaria Corp. Corporation true Christopher Bunka 100 - 740 McCurdy Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 2P7 Director John Docherty 100 - 740 McCurdy Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 2P7 Executive Officer Director Richard Christopher 100 - 740 McCurdy Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 2P7 Executive Officer Michael Shankman 100 - 740 McCurdy Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 2P7 Executive Officer NICHOLAS BAXTER 100 - 740 McCurdy Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 2P7 Director TED MCKECHNIE 100 - 740 McCurdy Road Kelowna A1 BRITISH COLUMBIA, CANADA V1Y 2P7 Director ALBERT REESE 100 - 740 McCurdy Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 2P7 Director CATHERINE TURKEL 100 - 740 McCurdy Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 2P7 Director Pharmaceuticals $5,000,001 - $25,000,000 06b false 2024-10-16 false true false 0 H.C. WAINWRIGHT & CO. 375 None None 420 Park Avenue 4th Floor New York NY NEW YORK 10022 NY NEW YORK false 5000000 5000000 0 Offering Amount is for the shares that were issued as registered securities, the unregistered warrants from part of the offering false 1 350000 0 Commission represents 7% of the offering amount 0 false Lexaria Bioscience Corp. /Richard Christopher/ Richard Christopher CEO 2024-10-16